Mirum Pharmaceuticals, Inc. - common stock — 재무제표 (NASDAQ:MIRM) | MetaTrader

전체 차트 열기 Full chart

Financials

개요 성명 통계

총자산 240.86 M294.65 M352.91 M646.62 M670.75 M842.81 M 총 부채 68.77 M174.44 M210.87 M397.95 M445.11 M528.12 M 자본금 총액 172.09 M120.21 M142.04 M248.67 M225.64 M314.69 M 총 부채 및 주주자본 240.86 M294.65 M352.91 M646.62 M670.75 M842.81 M 총부채 ———306.42 M308.08 M309.8 M 순부채 ———20.09 M27.77 M-73.53 M

뉴스

JPMorgan says large-cap biotech is back as profits and pipelines fuel upside

Nvidia, Amazon, SiTime Among New Names On IBD 50, Stock Spotlight And More

Mirum's Q1 Earnings & Revenues Beat Estimates, 2026 View Raised

Mirum Pharmaceuticals, Inc. (MIRM) Q1 2026 Earnings Call Transcript

Mirum Pharmaceuticals, Inc. (MIRM) Discusses Topline Clinical Results in Primary Sclerosing Cholangitis and Hepatitis Delta - Slideshow (NASDAQ:MIRM) 2026-05-06

Here's What Key Metrics Tell Us About Mirum Pharmaceuticals (MIRM) Q1 Earnings

Mirum Pharmaceuticals, Inc. (MIRM) Reports Q1 Loss, Beats Revenue Estimates

Mirum Pharmaceuticals, Inc. (MIRM) Discusses Topline Clinical Results in Primary Sclerosing Cholangitis and Hepatitis Delta Transcript

Amazon Hits All-Time High, Leads 20 Top Performers Onto Best Stock Lists

The $1 Billion-Plus Opportunity That Sent Mirum Pharma Catapulting To A Record

Mirum Pharmaceuticals, Inc. (MIRM) Expected to Beat Earnings Estimates: What to Know Ahead of Q1 Release

Biogen Inc. (BIIB) Tops Q1 Earnings and Revenue Estimates